Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-043356
Filing Date
2021-06-25
Accepted
2021-06-25 17:47:43
Documents
1
Period of Report
2021-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3888
  Complete submission text file 0001209191-21-043356.txt   5252
Mailing Address 5425 WISCONSIN AVE CHEVY CHASE MD 20815
Business Address
Behbahani Ali (Reporting) CIK: 0001613867 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40522 | Film No.: 211049226

Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Issuer) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)